US stocks were higher amid a backdrop of scattered earnings and the outbreak of a trade war with China.
Impinj (NASDAQ:PI) Misses Q4 Analysts’ Revenue Estimates, Stock Drops 20.9%
RFID manufacturer Impinj (NASDAQ:PI) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 29.6% year on year to $91.57 million. Next quarter’s revenue guidance of $71.5 million underwhelmed, coming in 22.8% below analysts’ estimates. Its non-GAAP profit of $0.48 per share was in line with analysts’ consensus estimates.
Tenable (NASDAQ:TENB) Posts Better-Than-Expected Sales In Q4 But Full-Year Sales Guidance Slightly Misses Expectations
Cybersecurity software maker Tenable (NASDAQ:TENB) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 10.5% year on year to $235.7 million. On the other hand, next quarter’s revenue guidance of $233 million was less impressive, coming in 1.1% below analysts’ estimates. Its non-GAAP profit of $0.41 per share was 19% above analysts’ consensus estimates.
CONMED (NYSE:CNMD) Beats Q4 Sales Targets But Stock Drops
Medical tech company CONMED (NYSE:CNMD) announced better-than-expected revenue in Q4 CY2024, with sales up 5.8% year on year to $345.9 million. On the other hand, the company’s full-year revenue guidance of $1.36 billion at the midpoint came in 2.7% below analysts’ estimates. Its non-GAAP profit of $1.34 per share was 11.4% above analysts’ consensus estimates.
Amtech’s (NASDAQ:ASYS) Q4 Sales Top Estimates But Quarterly Revenue Guidance Significantly Misses Expectations
Semiconductor production equipment provider Amtech Systems (NASDAQ:ASYS) announced better-than-expected revenue in Q4 CY2024, but sales fell by 2.1% year on year to $24.39 million. On the other hand, next quarter’s revenue guidance of $22 million was less impressive, coming in 14.1% below analysts’ estimates. Its non-GAAP profit of $0.02 per share was significantly above analysts’ consensus estimates.
Qualcomm (NASDAQ:QCOM) Reports Strong Q4, Next Quarter’s Sales Guidance is Optimistic
Wireless chipmaker Qualcomm (NASDAQ:QCOM) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 17.5% year on year to $11.67 billion. On top of that, next quarter’s revenue guidance ($10.75 billion at the midpoint) was surprisingly good and 4.2% above what analysts were expecting. Its non-GAAP profit of $3.41 per share was 14.9% above analysts’ consensus estimates.
Old Dominion poised to take share when market turns
Old Dominion Freight Line is planning for a good 2025 back half and hasn’t given up on the first half yet. The post Old Dominion poised to take share when market turns appeared first on FreightWaves.
No Surprises In Skyworks Solutions’s (NASDAQ:SWKS) Q4 Sales Numbers, Provides Optimistic Revenue Guidance for Next Quarter
Wireless chips maker Skyworks Solutions (NASDAQ: SWKS) met Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 11.1% year on year to $1.07 billion. The company expects next quarter’s revenue to be around $950 billion, coming in 100,716% above analysts’ estimates. Its non-GAAP profit of $1.60 per share was 1.7% above analysts’ consensus estimates.
Hologic (NASDAQ:HOLX) Reports Q4 In Line With Expectations But Full-Year Sales Guidance Misses Expectations
Medical technology company Hologic (NASDAQ:HOLX) met Wall Street’s revenue expectations in Q4 CY2024, but sales were flat year on year at $1.02 billion. On the other hand, next quarter’s revenue guidance of $1 billion was less impressive, coming in 3.2% below analysts’ estimates. Its non-GAAP profit of $1.03 per share was 1.4% above analysts’ consensus estimates.
FormFactor (NASDAQ:FORM) Reports Q4 In Line With Expectations But Stock Drops 21.5%
Semiconductor testing company FormFactor (NASDAQ:FORM) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 12.7% year on year to $189.5 million. On the other hand, next quarter’s revenue guidance of $170 million was less impressive, coming in 11.6% below analysts’ estimates. Its non-GAAP profit of $0.27 per share was 7.3% below analysts’ consensus estimates.